Skill UI

Generates publication-ready clinical decision support documents for pharma and clinical research, covering biomarker-stratified cohort analysis, evidence-graded treatment recommendations, statistical comparisons, and regulatory-ready LaTeX/PDF outputs.

Query the NIH Metabolomics Workbench via REST API to fetch metabolites, RefMet nomenclature, mass-spec searches, and detailed study datasets for biomarker discovery and metabolomics research.

Access DepMap data to fetch CRISPR Chronos dependency scores, drug sensitivity readouts, and gene effect profiles for cancer cell lines, supporting target validation, biomarker discovery, and synthetic-lethality research via API or downloads.

Retrieves and analyzes Cancer Dependency Map release data, including CRISPR Chronos gene effects, model annotations, omics biomarkers, and PRISM drug sensitivity for selective dependency and synthetic-lethality analyses.

A comprehensive guide for authors assessing the suitability of their clinical or translational oncology studies for Annals of Oncology (ESMO). It covers the journal's high standards for rigorous, practice-changing research, including requirements for robust trial design, biomarker validation, adherence to specific reporting guidelines (CONSORT, STROBE), and alignment with ESMO best practices. This is a venue-fit aid, not medical or regulatory advice.

This guide helps researchers determine if their study—particularly in clinical neurology or translational neuroscience—meets the high standards of leading journals like Brain. It provides detailed insights into required mechanistic depth, evidence types (e.g., genetics, biomarkers), appropriate reporting guidelines (STROBE, CONSORT, PRISMA), and common desk-reject expectations. It is a venue-fit aid, detailing the scientific rigor needed for submission.

This skill guides authors on assessing if their cardiovascular manuscript meets the rigorous standards of Circulation, the AHA's flagship journal. It covers the journal's specific scope, ideal research methods (e.g., RCTs, biomarker studies, epidemiology), structural requirements, and how to effectively frame the work to impact AHA guidelines and clinical practice.

This skill provides a comprehensive guide for authors submitting clinical, translational, or epidemiological oncology studies to JAMA Oncology. It covers venue fit assessment, required methodological rigor (e.g., RCTs, RWE, biomarker validation), mandatory reporting guidelines (CONSORT, STROBE, PRISMA), and adherence to the journal's specific house style and submission checklist. It is a crucial pre-submission aid, ensuring the research addresses a clinically meaningful, decision-relevant question.

A comprehensive skill designed for authors targeting the Journal of Clinical Oncology (JCO). It provides an exhaustive checklist covering the journal's high academic standards, required evidence depth (such as Phase III randomized controlled trials), appropriate study scope (solid tumors, biomarkers), mandatory formatting, and the latest submission guidelines. Use this tool to optimize your manuscript and improve its suitability for publication in a top-tier oncology journal.

A comprehensive guide for authors targeting high-impact hepatology journals, such as the Journal of Hepatology. It assesses the fit of liver-disease studies, outlines the required evidence bar (e.g., powered clinical endpoints, biomarker validation), and details mandatory reporting guidelines (CONSORT, STROBE, PRISMA). This skill aids in manuscript re-framing and ensures compliance with EASL/Elsevier house styles before submission.

A comprehensive guide for authors to determine if their manuscript meets the stringent standards of Science Translational Medicine. This skill assesses the necessary dual mandate: demonstrating both a solid mechanistic insight and a credible, measurable clinical translation arc (drug, device, or biomarker). It covers scope fit, required human evidence standards, necessary preclinical validation, and specific structural requirements for submission.

This comprehensive skill acts as a venue-selection and re-framing tool for authors targeting The Lancet Oncology. It provides deep insight into the journal's specific requirements, including methodological rigor (CONSORT, PRISMA), required evidence strength (Phase III RCTs, definitive biomarkers), structural elements (structured abstract, 'Added value' panel), and current submission best practices. Use this guide to assess if your clinical oncology manuscript is sufficiently advanced and impactful for this prestigious global journal.